Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis

Journal of Clinical Sleep Medicine

Volumn 9, Issue 6, 2013, Pages 593-601

  Kolilekas, Likurgos ^a,b   Manali, Effrosyni ^c   Vlami, Katerina A ^a   Lyberopoulos, Panagiotis ^a   Triantafillidou, Christina ^a,b   Kagouridis, Konstantinos ^a   Baou, Katerina ^a   Gyftopoulos, Sotirios ^a   Vougas, Konstantinos N ^d   Karakatsani, Anna ^a   Alchanatis, Manos ^c   Papiris, Spyros ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Exercise limitation and testing; Idiopathic pulmonary fibrosis; Sleep disordered breathing; Sleep oxygen desaturation; Survival

Indexed keywords

AGED; APNEA HYPOPNEA INDEX; ARTICLE; EXERCISE TEST; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXYGEN DESATURATION; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SLEEP; SLEEP DISORDERED BREATHING; SURVIVAL;

EXERCISE LIMITATION AND TESTING; IDIOPATHIC PULMONARY FIBROSIS; SLEEP DISORDERED BREATHING; SLEEP OXYGEN DESATURATION; SURVIVAL;

AGED; COMORBIDITY; DISEASE PROGRESSION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; GREECE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; LIKELIHOOD FUNCTIONS; MALE; OXYGEN; PROSPECTIVE STUDIES; SLEEP APNEA SYNDROMES; SURVIVAL RATE;

EID: 84880000480     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.2758     Document Type: Article

References (46)

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 2011;183:788-824.
2. Lancaster LH, Mason W, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009;136:772-8.
3. Mermigkis C, Stagaki E, Tryfon S, et al. How common is sleep disordered breathing in patients with idiopathic pulmonary fibrosis. Sleep Breath 2010;14:387-90.
4. Krishnan V, McCormack MC, Mathai SC, et al. Sleep quality and health related quality of life in idiopathic pulmonary fibrosis. Chest 2008;134:693-8.
5. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005;60:588-94. (Pubitemid 40966214)
6. Manali ED, Lyberopoulos P, Triantafillidou C, et al. The Medical Research Council chronic dyspnea scale: relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients. BMC Pulm Med 2010;10:32.
7. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6MWT in Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:1084-90. (Pubitemid 37338937)
8. ATS Statement: Guidelines for the 6 minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
9. ATS/ACCP Statement of cardiopulmonary testing. Am J Respir Crit Care Med 2003;167:211-77.
10. Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
11. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;28:499-521. (Pubitemid 40489844)
12. Perez-Padilla R, West P, Lertzmann M, Kryger MH. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1985;132:224-9. (Pubitemid 15229371)
13. Bye PT, Issa F, Berthon-Jones M, Sullivan CE. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1984;129:27-32. (Pubitemid 14176497)
14. Johns MW. A new method of measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991;14:540-5.
15. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179:615-21.
16. Galliè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009;30:2493-537.
17. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/.J. 2011.
18. Clark M, Cooper B, Singh S, Cooper M, Carr A, Hubbard R. A survey of nocturnal hypoxemia and health related quality of life in patients with cryptogenic fibrosing alveolitis. Thorax 2001;56:482-6. (Pubitemid 32521368)
19. Corte TJ, Wort SJ, Talbot S, et al. Elevated nocturnal desaturation index predicts mortality in interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2012;22:41-50.
20. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006;174:803-9. (Pubitemid 44511662)
21. Lama VN, Martinez FJ. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med 2004;25:435-53. (Pubitemid 39149796)
22. Corte TJ, Wort SJ, Wells AU. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Sarcoidosis Vasc Diffuse Lung Dis 2009;26:7-19.
23. Corte TJ, Wort SJ, Gatzoulis MA, Macdonald P, Hansell DM, Wells AU. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax 2009;64:883-8.
24. Corte TJ, Wort SJ, Gatzoulis MA, et al. Elevated Brain natriuretic peptide predicts mortality in interstitial lung disease. Eur Respir J 2010;36:819-25.
25. Lévy P, Pépin JL, Arnaud C, et al. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives. Eur Respir J 2008;32:1082-95.
26. Trakada G, Nikolaou E, Pouli A, Tsiamita M, Spiropoulos K. Endothelin-1 levels in interstitial lung disease patients during sleep. Sleep Breath 2003;7:111-8.
27. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007;11:117-24. (Pubitemid 46745864)
28. Neubauer JA. Invited review: physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 2001;90:1593-9.
29. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5. (Pubitemid 23115702)
30. Chaouat A, Weitzenblum E, Krieger J, Ifounza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995;151:82-6.
31. Sériès F, Cormier Y, Desmeules M. Influence of passive changes of lung volume on upper airways. J Appl Physiol 1990;68:2159-64. (Pubitemid 20183110)
32. Sériès F, Marc I. Influence of lung volume dependence of upper airway resistance during continuous negative airway pressure. J Appl Physiol 1994;77:840-4. (Pubitemid 24258320)
33. Hoffstein V, Zamel N, Phillipson EA. Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis 1984;130:175-8. (Pubitemid 14055799)
34. Onal E, Leech JA, Lopata M. Relationship between pulmonary function and sleep-induced respiratory abnormalities. Chest 1985;87:437-41. (Pubitemid 15083478)
35. Heinzer RC, Stanchina ML, Malhotra A, et al. Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:114-7. (Pubitemid 40923322)
36. Tagaito Y, Isono S, Remmers JE, Tanaka A, Nishino T. Lung volumes and collapsibility of the passive pharynx in patients with sleep disordered breathing. J Appl Physiol 2007;103:1379-85. (Pubitemid 47605977)
37. Nena E, Steiropoulos P, Papanas N, et al. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. Sleep Breath 2012;16:181-6.
38. Alameri H, Al-Kabab Y, BaHammam A. Submaximal exercise in pateints with severe obstructive sleep apnea. Sleep Breath 2010;14:145-51.
39. Przybylowski T, Bielicki P, Kumor M, et al. Exercise capacity in patients with obstructive sleep apnea syndrome. J Physiol Pharmacol 2007;58:563-74. (Pubitemid 351346706)
40. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects and disease progression. Int J Chron Obstruct Pulm Dis 2011;6:199-208.
41. Medeiros P Jr, Lorenzi-Filho G, Pimenta SP, Kairalla RA, Carvalho CRR. Sleep desaturation and its relationship to lung function, exercise and quality of life in LAM. Respir Med 2012;106:420-8.
42. Midgren B, Hansson L, Eriksson L, Airikkala P, Elmqvist D. Oxygen desaturation during sleep and exercise in patients with interstitial lung disease. Thorax 1987;42:353-6. (Pubitemid 17070851)
43. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-8.
44. Marin JM, Carrizo SJ, Vicente E, et al. Long term cardiovascular outcomes in men with obstructive sleep apnea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. (Pubitemid 40386782)
45. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: the overlap syndrome. Am J Respir Crit Care Med 2010;182:325-31.
46. Karakatsani A, Papakosta D, Rapti A, et al Hellenic Interstitial Lung Diseases Group. Epidemiology of interstitial lung diseases in Greece. Respir Med 2009;103:1122-9.